1. High throughput screening identifies repurposable drugs for modulation of innate and acquired immune responses.
- Author
-
Ghorbanalipoor, Saeedeh, Matsumoto, Kazuko, Gross, Natalie, Heimberg, Linda, Krause, Malin, Veldkamp, Wendelien, Magens, Moritz, Zanken, Johannes, Neuschutz, Kerstin J., De Luca, David A., Kridin, Khalaf, Vidarsson, Gestur, Chakievska, Lenche, Visser, Remco, Kunzel, Sven, Recke, Andreas, Gupta, Yask, Boch, Katharina, Vorobyev, Artem, and Kalies, Kathrin
- Subjects
- *
HIGH throughput screening (Drug development) , *B cells , *T cells , *CHEMICAL libraries , *NONPRESCRIPTION drugs - Abstract
A balanced immune system is essential to maintain adequate host defense and effective self-tolerance. While an immune system that fails to generate appropriate response will permit infections to develop, uncontrolled activation may lead to autoinflammatory or autoimmune diseases. To identify drug candidates capable of modulating immune cell functions, we screened 1200 small molecules from the Prestwick Chemical Library for their property to inhibit innate or adaptive immune responses. Our studies focused specifically on drug interactions with T cells, B cells, and polymorphonuclear leukocytes (PMNs). Candidate drugs that were validated in vitro were examined in preclinical models to determine their immunomodulatory impact in chronic inflammatory diseases, here investigated in chronic inflammatory skin diseases. Using this approach, we identified several candidate drugs that were highly effective in preclinical models of chronic inflammatory disease. For example, we found that administration of pyrvinium pamoate, an FDA-approved over-the-counter anthelmintic drug, suppressed B cell activation in vitro and halted the progression of B cell-dependent experimental pemphigoid by reducing numbers of autoantigen-specific B cell responses. In addition, in studies performed in gene-deleted mouse strains provided additional insight into the mechanisms underlying these effects, for example, the receptor-dependent actions of tamoxifen that inhibit immune-complex-mediated activation of PMNs. Collectively, our methods and findings provide a vast resource that can be used to identify drugs that may be repurposed and used to promote or inhibit cellular immune responses. [Display omitted] • 1200 molecules from the Prestwick Chemical Library were screened for their capacity to inhibit innate or adaptive immunity. • Topotecan and ciclopirox block the induction of T cell-dependent psoriasiform dermatitis. • Pyrvinium pamoate suppressed B cell activation in vitro and halted the progression of B cell-dependent pemphigoid disease. • Amodiaquine, apomorphine, and tamoxifen block neutrophil-driven skin inflammation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF